We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Quantitative detection of a cocktail of mycobacterial MPT64 and PstS1 in tuberculosis patients by real-time immuno-PCR

    Suman Sharma

    Centre for Biotechnology, Maharshi Dayanand University, Rohtak-124001, India

    ,
    Abhishek Sheoran

    Department of Statistics, Ramanujan College, University of Delhi, New Delhi-110019, India

    ,
    Krishna B Gupta

    Department of TB & Respiratory Medicine, University of Health Sciences, Rohtak-124001, India

    ,
    Aparna Yadav

    Department of Microbiology, University of Health Sciences, Rohtak-124001, India

    ,
    Mandira Varma-Basil

    Microbiology Department, Vallabhbhai Patel Chest Institute, University of Delhi, New Delhi-110007, India

    ,
    Vishnubhatla Sreenivas

    Department of Biostatistics, All India Institute of Medical Sciences, New Delhi-110029, India

    ,
    Dhruva Chaudhary

    Department of Pulmonary & Critical Care Medicine, University of Health Sciences, Rohtak-124001, India

    &
    Promod K Mehta

    *Author for correspondence: Tel.: +91 989 650 4193; Fax: +91 126 227 4640;

    E-mail Address: pkmehta3@hotmail.com

    Centre for Biotechnology, Maharshi Dayanand University, Rohtak-124001, India

    Published Online:https://doi.org/10.2217/fmb-2018-0284

    Aim: There is an urgent need to design a reliable diagnostic test for tuberculosis (TB). Methods: Real-time immuno-PCR (RT-I-PCR) assay was devised for the quantitative detection of a cocktail of mycobacterial MPT64 (Rv1980c) and PstS1 (Rv0934) in TB patients. Results: A broad dynamic range of 0.95 pg/ml–95 ng/ml of MPT64+PstS1 was detected in TB patients. In smear-positive (n = 59) and smear-negative (n = 42) pulmonary TB cases, sensitivities of 93.2 and 83.3% were observed, respectively with 92.8% specificity, whereas a sensitivity of 77.9% and a specificity of 91.3% were observed in extrapulmonary TB cases (n = 86). Furthermore, significantly reduced MPT64+PstS1 concentrations (p < 0.001) were noticed in patients on therapy by RT-I-PCR as compared with untreated patients. Conclusion: Our RT-I-PCR assay revealed high sensitivity especially for the rapid diagnosis of smear-negative pulmonary TB and paucibacillary extrapulmonary TB samples, which could also monitor the dynamics of disease in patients on therapy.

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1 WHO. Global tuberculosis control. WHO Report. WHO, Geneva (2018). www.who.int/tb/publications/global_report/en/.
    • 2 Mehta PK, Raj A, Singh N, Khuller GK. Diagnosis of extrapulmonary tuberculosis by PCR. FEMS Immunol. Med. Microbiol. 66(1), 20–36 (2012).
    • 3 Caulfield AJ, Wengenack NL. Diagnosis of active tuberculosis disease: from microscopy to molecular techniques. J. Clin. Tuberc. Other Mycobact. Dis. 1(4), 33–43 (2016).
    • 4 Peralta G, Barry P, Pascopella L. Use of nucleic acid amplification tests in tuberculosis patients in California. Open Forum Infect. Dis. 3(4), ofw230 (2016).
    • 5 Sehgal IS, Dhooria S, Aggarwal AN, Behera D, Agarwal R. Diagnostic performance of Xpert MTB/RIF in tuberculous pleural effusion: systematic review and meta-analysis. J. Clin. Microbiol. 54(4), 1133–1136 (2016).
    • 6 Sharma S, Dahiya B, Sreenivas V et al. Comparative evaluation of GeneXpert MTB/RIF and multiplex PCR targeting mpb64 and IS6110 for the diagnosis of pleural tuberculosis. Future Microbiol. 13, 407–413 (2018). • Describes the comparative evaluation of Xpert assay and multiplex PCR (mpb64 and IS6110) for the diagnosis of tuberculosis (TB) pleuritis.
    • 7 Mehta PK, Raj A, Singh NP, Khuller GK. Detection of potential microbial antigens by immuno-PCR (PCR-amplified immunoassay). J. Med. Microbiol. 63(5), 627–641 (2014). •• Presents a review for the detection of potential viral, bacterial and parasitic antigens by immuno-PCR (I-PCR) and emphasizes the superiority of I-PCR over analogous ELISA.
    • 8 Mehta PK, Dahiya B, Sharma S et al. Immuno-PCR, a new technique for the serodiagnosis of tuberculosis. J. Microbiol. Methods 139, 218–229 (2017). • Presents a comprehensive review on the detection of Mycobacterium tuberculosis antigens and antibodies in bodily fluids of TB patients by I-PCR.
    • 9 Singh N, Sreenivas V, Gupta KB, Chaudhary A, Mittal A, Varma-Basil M. Diagnosis of pulmonary and extrapulmonary tuberculosis based on detection of mycobacterial antigen 85B by immuno-PCR. Diagn. Microbiol. Infect. Dis. 83, 359–364 (2015). •• Details the detection of immunodominant Ag85B in TB patients by I-PCR.
    • 10 Bekmurzayeva A, Sypabekova M, Kanayeva D. Tuberculosis diagnosis using immunodominant, secreted antigens of Mycobacterium tuberculosis. Tuberculosis (Edinb.) 93(4), 381–388 (2013).
    • 11 Landowski CP, Godfrey HP, Bentley-Hibbert SI et al. Combinatorial use of antibodies to secreted mycobacterial proteins in a host immune system-independent test for tuberculosis. J. Clin. Microbiol. 39(7), 2418–2424 (2001).
    • 12 Mehta PK, Kalra M, Khuller GK, Behera D, Verma I. Development of an ultrasensitive polymerase chain reaction-amplified immunoassay based on mycobacterial RD antigens: implications for the serodiagnosis of tuberculosis. Diagn. Microbiol. Infect. Dis. 72(2), 166–174 (2012). •• Presents the detection of a cocktail of M. tuberculosis RD antigens, i.e. ESAT-6, CFP-21, etc. in bodily fluids of TB patients by I-PCR.
    • 13 Oettinger T, Andersen AB. Cloning and B-cell-epitope mapping of MPT64 from Mycobacterium tuberculosis H37Rv. Infect. Immun. 62(5), 2058–2064 (1994).
    • 14 Kanade S, Nataraj G, Suryawanshi R, Mehta P. Utility of MPT 64 antigen detection assay for rapid characterization of mycobacteria in a resource constrained setting. Indian J. Tuberc. 59(2), 92–96 (2012).
    • 15 Freeman R, Magee J, Barratt A et al. Rapid immunochromatographic assay for diagnosis of tuberculosis: antibodies detected may not be specific. J. Clin. Microbiol. 37(6), 2111–2112 (1999).
    • 16 Haldar S, Sankhyan N, Sharma N et al. Detection of Mycobacterium tuberculosis GlcB or HspX Antigens or devR DNA impacts the rapid diagnosis of tuberculous meningitis in children. PLoS ONE 7, e44630 (2012).
    • 17 Sharma S, Raj A, Singh N, Dahiya B et al. Development of real-time immuno-PCR for the quantitative detection of mycobacterial PstS1 in tuberculosis patients. J. Microbiol. Methods 132, 134–138 (2017). • Describes the development of real-time-I-PCR to detect PstS1 protein in TB patients.
    • 18 Singh N, Sreenivas V, Sheoran A et al. Serodiagnostic potential of immuno-PCR using a cocktail of mycobacterial antigen 85B, ESAT-6 and cord factor in tuberculosis patients. J. Microbiol. Methods 120, 56–64 (2016).
    • 19 India TB Report 2018. Revised National TB Control Program. https://tbcindia.gov.in/showfile.php?lid=3314.
    • 20 R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, 2018 Vienna, Austria. www.R-project.org/.
    • 21 Niemeyer CM, Adler M, Wacker R. Detecting antigens by quantitative immuno-PCR. Nat. Protoc. 2(8), 1918–1930 (2007).
    • 22 Laushkina Z, Cherednichenko A. Estimation of the role of the test GeneXpert MTB/RIF in the diagnosis of pulmonary tuberculosis. Eur. Respir. J. 44, P2677 (2014). • Details the utility of Xpert assay for the diagnosis of pulmonary TB cases.
    • 23 Meldau R, Peter J, Theron G et al. Comparison of same day diagnostic tools, including GeneXpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort study. BMC Pulm. Med. 14, 58 (2014).
    • 24 Sarfaraz S, Iftikhar S, Memon Y, Zahir N, Hereker FF, Salahuddin N. Histopathological and microbiological findings and diagnostic performance of GeneXpert in clinically suspected tuberculous lymphadenitis. Int. J. Infect. Dis. 76, 73–81 (2018). •• Describes the utility of Xpert assay for detecting TB lymphadenitis.
    • 25 Theron G, Peter J, van Zyl-Smit R et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am. J. Respir. Crit. Care Med. 184(1), 132–140 (2011).
    • 26 Zeka AN, Tasbakan S, Cavusoglu C. Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and exrapulmonary specimens. J. Clin. Microbiol. 49(12), 4138–4141 (2011).
    • 27 Lyashchenko K, Colangeli R, Houde M, Al Jahdali H, Menzies D, Gennaro ML. Heterogeneous antibody responses in tuberculosis. Infect. Immun. 66(8), 3936–3940 (1998).
    • 28 Kalra M, Khuller GK, Grover A et al. Utility of a combination of RD1 and RD2 antigens as a diagnostic marker for tuberculosis. Diagn. Microbiol. Infect. Dis. 66(2), 153–161 (2010).
    • 29 Perez JW, Adams NM, Zimmerman GR, Haselton FR, Wright DW. Detecting respiratory syncytial virus using nanoparticle-amplified immuno-PCR. Methods Mol. Biol. 1026, 93–110 (2013).
    • 30 Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M, Steingart KR. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur. Respir. J. 44(2), 435–446 (2014).
    • 31 Dorman SE, Schumacher SG, Alland D et al. Xpert MTB/RIF ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect. Dis. 18(1), 76–84 (2018).
    • 32 Silva VM, Kanaujia G, Gennaro ML, Menzies D. Factors associated with humoral response to ESAT-6, 38kDa and 14kDa antigens in patients with a spectrum of tuberculosis. Int. J. Tuberc. Lung Dis. 7(5), 478–484 (2003).
    • 33 Zhu C, Liu J, Ling Y et al. Evaluation of the clinical value of ELISA based on MPT64 antibody aptamer for serological diagnosis of pulmonary tuberculosis. BMC Infect. Dis. 12, 96 (2012).
    • 34 Barletta J, Bartolome A, Constantine NT. Immunomagnetic quantitative immuno-PCR for detection of less than one HIV-1 virion. J. Virol. Methods 157(2), 122–132 (2009).